newsfilter
← Latest News
GlobeNewswire·

Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights

– Final stage of technical evaluation near completion in Comera's research collaboration with Regeneron, a leading U.S. biotechnology company – – Expanded and strengthened Comera's global patent portfolio, broadening